This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Product Surveillance Registry (PSR)

This study is currently recruiting participants.
See Contacts and Locations
Verified January 2017 by Medtronic
Sponsor:
Information provided by (Responsible Party):
Medtronic
ClinicalTrials.gov Identifier:
NCT01524276
First received: January 30, 2012
Last updated: January 13, 2017
Last verified: January 2017
  Purpose
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Condition
Cardiac Rhythm Disorders Urological and Digestive Disorders Neurological Disorders Cardiovascular Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Medtronic Product Surveillance Registry

Further study details as provided by Medtronic:

Primary Outcome Measures:
  • Safety and Effectiveness of Market Released products [ Time Frame: Every 6-12 months (Therapy-dependent) ]

Estimated Enrollment: 50000
Study Start Date: January 2012
Estimated Primary Completion Date: January 2024 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects implanted with Medtronic qualifying therapy product.
Criteria

Inclusion Criteria:

  • Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • Patient has or is intended to receive or be treated with an eligible Medtronic product
  • Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Exclusion Criteria:

  • Patient who is, or will be, inaccessible for follow-up
  • Patient with exclusion criteria required by local law
  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01524276

Contacts
Contact: Medtronic Product Surveillance Registry rs.productsurveillanceregistry@medtronic.com

  Show 238 Study Locations
Sponsors and Collaborators
Medtronic
  More Information

Responsible Party: Medtronic
ClinicalTrials.gov Identifier: NCT01524276     History of Changes
Other Study ID Numbers: PSR
Study First Received: January 30, 2012
Last Updated: January 13, 2017

Additional relevant MeSH terms:
Disease
Nervous System Diseases
Digestive System Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac
Pathologic Processes
Heart Diseases

ClinicalTrials.gov processed this record on June 23, 2017